Nutrition, Microbiome and Bone Health During Early Life Related to Health

NCT ID: NCT05160675

Last Updated: 2025-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2760 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-03

Study Completion Date

2025-09-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to establish the longitudinal microbiome and bone trajectories from birth to 3 years, and to evaluate the influence of nutrition on these trajectories.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of the study is to understand the influence of nutrition and dietary patterns on microbiome and bone trajectories during early life. Specific research objectives are:

* Establish the reference trajectories of gut microbiome maturation index and bone development in healthy Chinese children aged 0-3years
* Assess the impact of early life nutrition on gut microbiome trajectory
* Investigate the influence of microbiome, early life parameters and nutritional parameters on bone health

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Group 1: 690 healthy infants and their mother followed from birth to 12 months

Intervention Type OTHER

No intervention

Group 2

Group 2: 690 healthy infants and their mother followed from 6 months to 3 years of age

Intervention Type OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Having obtained his/her parents' (or his/her legally accepted representative's \[LAR's\]) written informed consent and having evidence of personally signed and dated informed consent document indicating that the subject's parents/LAR have been informed of all pertinent aspects of the study.
2. Subject's parent(s)/LAR is of legal age of consent, is willing and able to fulfill the requirements of the study protocol.
3. For group 1, healthy infants aged ≤ 10 days after birth (date of birth = Day 0).

For group 2, healthy infants with maximum age of 6 months
4. Full-term gestational birth (≥ 37 and ≤ 42 weeks).
5. Subject's parent(s)/LAR is able to be contacted directly by telephone throughout the study.
6. Both parents registered have a fixed work and / or residence within their jurisdiction.

Exclusion Criteria

1. Complicated pregnancy (e.g., preeclampsia, gestational diabetes, bowel disease) as assessed by medical interview/ medical record when available
2. Infant's parents/LAR not willing and/or not able to comply with scheduled visits and the requirements of the study protocol
3. Currently participating or having participated in another clinical trial within 4 weeks prior to trial start.
Minimum Eligible Age

0 Days

Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tianjin Women and Children's Health Center

OTHER

Sponsor Role collaborator

BGI-research

OTHER

Sponsor Role collaborator

Cognizant Technology Solutions AG

UNKNOWN

Sponsor Role collaborator

SAS Institute

INDUSTRY

Sponsor Role collaborator

Veeva Systems

INDUSTRY

Sponsor Role collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gongshu Liu, Dr.

Role: PRINCIPAL_INVESTIGATOR

Tianjin Women and Children Health Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tianjin Women and Children Health Center,

Tianjin, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20.27.NRC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bone Health in Pregnancy
NCT01145573 COMPLETED NA
Move Study in Healthy Aging People
NCT02276183 COMPLETED NA
Bone Markers in Pediatric IF
NCT05909228 COMPLETED
Shape Up! Kids Study
NCT03706612 COMPLETED
TRE: Microbiome, Metabolic Health and Bone
NCT05548517 ACTIVE_NOT_RECRUITING NA